Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children

Table 1

Demographic and clinical data of study population variable.

Total number of patients	30 (100%)
Preterm	22 (73.3%)
Fullterm	8 (26.6%)
Age at initiation of treatment (month),
Mean ± SD	𝟑.𝟕±2.5
Gender, 𝑛 (%)
Male	9 (30%)
Female	21 (70%)
Type, 𝑛 (%)
Localized	18 (60%)
Segmental	9 (30%)
Multifocal	3 (10%)
Location of IH, 𝑛 (%)
Facial Segments:
Frontotemporal (seg.1)	3 (10%)
Maxillary (seg.2)	5 (16.6%)
Mandibular (seg.3)	8 (26.6%)
Frontonasal (seg.4)	2 (6.6%)
Other locations:
Trunk	8 (26.6%)
Extremities	3 (10%)
Neck	1 (3.3%)
Duration of treatment till resolution (month),	𝟗.𝟒±𝟐.𝟔
Mean (range)	(6–14)
Side effects of treatment, 𝑛 (%)
Tachypnea	2 (6.6%)
Hypoglycemia	1 (3.3%)
Cold extrmities	1 (3.3%)
Constipation	2 (6.6%)